Novo Nordisk A/S ADR buy Sanford C. Bernstein
Start price
18.03.26
/
50%
€32.60
Target price
18.03.27
€151.71
Performance (%)
21.29%
Price
20.08.26
€39.54
Summary
This prediction is currently active. The prediction currently has a performance of 21.29%. This prediction currently runs until 18.03.27. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -2.467% | -2.467% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NVO) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $175.00 price target on the stock.
Ratings data for NVO provided by MarketBeat